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A Soluble Peripherin/Rds C-Terminal Polypeptide Promotes Membrane Fusion
and Changes Conformation Upon Membrane Association
Abstract
Photoreceptor rod cells contain a unique tetraspanin fusion protein known as peripherin/rds. This protein
is important in membrane fusion events hypothesized to be essential to disk membrane morphogenesis
and disk shedding. In vivo and in vitro fusogenic activity has been mapped to the C-terminal domain of
peripherin/rds. Moreover, a fusion peptide domain localized to a 15 amino acid long region (residues
311-325) is essential for mediating lipid bilayer fusion of model membranes. To address the functional
and structural properties required for peripherin/rds dependent membrane fusion, constructs of the entire
C-terminal domain (residues 284-346) were generated and polypeptides expressed. A wild typeperipherin/rds C-terminal GST fusion construct that included the entire C-terminus (PERCTER) or a Cterminal truncation mutant (PERCTN) were engineered with a thrombin cleavage site. Protein expression
was induced in E. coli with IPTG, expressed proteins cleaved from the GST with thrombin and purified to
homogeneity on a Superdex 75 column. Purity was confirmed by SDS-PAGE and Western blot analysis.
The purified wt C-terminal protein resolved as a monomer under reducing conditions on SDS-PAGE (15%)
and was immunoreactive with anti peripherin/rds antibody 2B6 (gift from Dr R. Molday). The purified
polypeptide promoted the requisite steps of fusion, membrane destabilization, lipid mixing and aqueous
contents mixing. Conversely, the truncation mutant lacking a portion of the fusion domain was unable to
promote these steps. A common feature of most membrane fusion proteins is a change in conformation
upon membrane association. Structural changes in the C-terminal polypeptide were investigated using far
UV CD. The far UV CD spectra of the purified C-terminal polypeptide indicated substantial α-helical
content in the wt peptide in isotonic aqueous buffer. An increase in intensity of 208 and 222 nm CD bands
upon addition of DPC vesicles indicated an increase in α-helical content of the polypeptide. These results
demonstrate that a purified soluble form of the C-terminus of peripherin/rds can interact with biological
phospholipids; moreover, this interaction promotes a conformational change that is most consistent with
an increase in α-helical content. © 2003 Elsevier Ltd. All rights reserved.
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Abstract
Photoreceptor rod cells contain a unique tetraspanin fusion protein known as peripherin/rds. This protein is important in membrane fusion
events hypothesized to be essential to disk membrane morphogenesis and disk shedding. In vivo and in vitro fusogenic activity has been
mapped to the C-terminal domain of peripherin/rds. Moreover, a fusion peptide domain localized to a 15 amino acid long region (residues
311– 325) is essential for mediating lipid bilayer fusion of model membranes. To address the functional and structural properties required for
peripherin/rds dependent membrane fusion, constructs of the entire C-terminal domain (residues 284– 346) were generated and polypeptides
expressed. A wild type-peripherin/rds C-terminal GST fusion construct that included the entire C-terminus (PERCTER) or a C-terminal
truncation mutant (PERCTN) were engineered with a thrombin cleavage site. Protein expression was induced in E. coli with IPTG, expressed
proteins cleaved from the GST with thrombin and purified to homogeneity on a Superdex 75 column. Purity was confirmed by SDS – PAGE
and Western blot analysis. The purified wt C-terminal protein resolved as a monomer under reducing conditions on SDS – PAGE (15%) and
was immunoreactive with anti peripherin/rds antibody 2B6 (gift from Dr R. Molday). The purified polypeptide promoted the requisite steps
of fusion, membrane destabilization, lipid mixing and aqueous contents mixing. Conversely, the truncation mutant lacking a portion of the
fusion domain was unable to promote these steps. A common feature of most membrane fusion proteins is a change in conformation upon
membrane association. Structural changes in the C-terminal polypeptide were investigated using far UV CD. The far UV CD spectra of the
purified C-terminal polypeptide indicated substantial a-helical content in the wt peptide in isotonic aqueous buffer. An increase in intensity
of 208 and 222 nm CD bands upon addition of DPC vesicles indicated an increase in a-helical content of the polypeptide. These results
demonstrate that a purified soluble form of the C-terminus of peripherin/rds can interact with biological phospholipids; moreover, this
interaction promotes a conformational change that is most consistent with an increase in a-helical content.
q 2003 Elsevier Ltd. All rights reserved.
Keywords: peripherin/rds; membrane fusion; photoreceptors; GST-fusion protein

1. Introduction
Membrane fusion is an essential component of cellular
events as diverse as endocytosis, exocytosis, fertilization,
viral entry into host cells and trancosytosis in polarized
epithelial cells (Pecheur et al., 1999; Wasserman, 1999;
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White 1992; Hernandez et al., 1996). Membrane fusion
events also play a critical role in the function of
photoreceptor rod cells, the cells that are responsible for
vision under low levels of light. These cells have an inner
segment and a highly specialized outer segment region. The
specialized outer segment contains a stack of closed
flattened membranous sacs known as disks that contain
the phototransduction protein rhodopsin. In these postmitotic cells, an active membrane renewal process is
required to maintain structural integrity and thereby normal
physiological function. The outer segment region maintains
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a constant number of disk membranes through the
coordinated processes of disk morphogenesis at the base
and a compensatory shedding of older disks at the apical tip
(Young, 1976). Both of these processes require membrane
fusion (for review see Boesze-Battaglia and Goldberg,
2001); at the disk base, evaginations of the ROS plasma
membrane fuse to form a closed disk membrane (Steinberg
et al., 1976); at the apical tip a series of older disks are
delineated from the remainder of the outer segment in disk
packets by a fusion of the disks with the plasma membrane
(Matsumoto and Besharse, 1985).
Previous work from this laboratory has identified a unique
photoreceptor specific fusion protein, peripherin/rds (a.k.a.
rds/peripherin and peripherin-2), proposed to mediate fusion
between membranes within the ROS (Boesze-Battaglia et al.,
1997; 1998). Peripherin/rds is a member of the tetraspanin
superfamily. It is localized exclusively to the rim region of
the disks (Arikawa et al., 1992) and it is oriented in the disk
membranes such that its N- and C-termini are exposed to the
cytoplasm (Connell and Molday, 1990). Studies investigating the effect of peripherin/rds mutations on fusion of
phospholipid bilayers identified amino acid residues 311–
325, located within the cytoplasmic C-terminus of peripherin/rds, as the minimal region required for membrane
binding and subsequent fusion (Boesze-Battaglia et al.,
1998). A peptide corresponding to this fusion region was
found to be an amphiphilic a-helix by FTIR (Boucheix and
Rubinstein, 2001; Boesze-Battaglia et al., 1997; 1998; 2000;
Muller-Weeks et al., 2002). Further studies of fusion in
phospholipid bilayers utilized a peptide analogue of the
fusion domain, called PP-5. These studies showed that fusion
competency requires a tetrameric arrangement of the fusion
peptide and by inference of the entire C-terminus
(Boesze-Battaglia et al., 2000). Recently, a highly conserved
region upstream of the fusion peptide domain (Stefano et al.,
2002) that includes a proline at position 295 was shown to
participate in the transition from a pre-fusion to a fusion
competent state of this protein (Stefano et al., 2002). Similar
regions have been identified as essential for conformational
changes of fusion proteins in intracellular fusion, neurotransmitter release and viral infectivity (Boucheix and
Rubinstein, 2001; Pecheuer et al., 2000; Weimbs et al.,
1997).
Biological membrane fusion may be mediated by a single
fusion protein or by fusion protein complexes specific to the
cell (Pecheur et al., 1999; Wasserman, 1999; White, 1992;
Hernandez et al., 1996; Pecheur et al., 2000; Weimbs et al.,
1997; Jones et al., 1998). Common properties of these
fusion proteins include multiple regions including a fusion
peptide domain (Young, 1976; Pecheur et al., 2000), a
‘fusion trigger’ region and a hairpin-like domain necessary
for the formation of a fusion pore (Weimbs et al., 1997). A
comprehensive analysis of the fusion proteins involved in
these processes and the processes themselves has provided a
paradigm having four clearly defined steps: cell adhesion,
close approach of the two opposing membrane, localized

membrane destabilization and mixing of the aqueous
contents (Bentz and Ellens, 1998). These steps require a
series of conformational changes within the fusion protein
complexes, as well as within the fusion peptide domain
(Bentz, 2000).
In this study we expressed the C terminal region of
peripherin/rds (residues 284 –346) as well as a truncated
version (residues 284– 318), which does contain an intact
fusion peptide. The soluble full-length C terminal polypeptide mediated the steps of membrane fusion while the
truncated version did not. These fusion studies indicate that
the properties inherent in the longer polypeptide are sufficient
to support its biological role as a membrane fusion protein in
the absence of anchorage to the membrane. Finally, we show
that the secondary structure of the peptide is sensitive to the
presence of a lipid environment in that the a-helical content
increases in the presence of the lipid. This type of structural
change is consistent with the formation of a coiled –coiled
intermediate as part of the molecular mechanism of the
fusion process. This work is of particular significance since
peripherin/rds is the first tetraspanin proposed to directly
mediate biological membrane fusion (Pecheur et al., 1999).

2. Materials and methods
Materials. N-methyl dioleoyl phosphatidylethanolamine
(N-methyl-DOPE), dodecylphosphatidylcholine (DPC),
phosphatidylcholine (egg), phosphatidylserine (egg) and
cholesterol were purchased from Avanti Polar Lipids
(Birmingham, AL). N-(7-nitro-2,1,3-benzoxadiazol-4-yl)
phosphatidylethanolamine (NBD-PE) and N-(lissamine
Rhodamine B sulfonyl) phosphatidylethanolamine (RhPE), 8-aminonaphtalene-1,3,6-trisulfonic acid sodium salt
(ANTS) and p-xylenebis(pyridinium) bromide (DPX) were
purchased from Molecular Probes (Eugene, USA).
Preparation of GST-C-terminal peripherin/rds construct
and purified protein. A glutathione S-transferase (GST)
fusion protein encoding the predicted 63 C-terminal amino
acids of bovine peripherin/rds, FPCTER, was produced
using conventional methology (Maniatus et al., 1989). A
130 bp PCR amplification product was obtained
using oligonucleotides primers (50 -TGTTGGATCCCGCTACCTGCACACG-30 and 50 -GGAGTACTAGTAACCCTGGCCCCAGTCACGACGTTGTAA-30 ), the coding
sequence of bovine peripherin/rds C-terminus (Connell
and Molday, 1990), and Taq polymerase. The PCR product
was digested with BamHI, purified, and ligated into BamHI
cut and purified pGEX-2T (Smith and Johnson, 1988) to
generate pFPCTER. Proper insert orientation was selected
by restriction mapping; insert and junction sequences were
verified by double-stranded DNA sequencing, using a Big
Dye terminator cycle sequencing kit (Applied Biosystems,
Inc.). Expression of the predicted 32 kDa fusion protein was
confirmed by induction of a TOP10F0 bacterial culture with
1 mM IPTG for 2 hr at 378C.
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A truncated version of the C-terminal fusion protein,
FPCTCN, was created by digesting pFPCTER with Stu I and
Sma I, then purifying and self-ligating the 5·1 kb fragment.
The completed construct was verified by double-stranded
DNA sequencing, using a Big Dye terminator cycle sequencing kit (Applied Biosystems, Inc.) The pFPCTCN plasmid
encodes a GST fusion protein joined to the N-terminal 34
amino acids of the peripherin/rds C-terminus. This truncation
interrupts the fusogenic helix (Boesze-Battaglia et al., 1997;
Boesze-Battaglia et al., 1998) with a stop codon at its
approximate midpoint. Expression of the predicted 29 kDa
fusion protein was confirmed by induction of TOP10F0
bacterial culture with 1 mM IPTG for 2 hr at 378C.
Cleavage of purified GST-C-terminal fusion proteins.
The full-length GST-C-terminal peripherin/rds fusion
protein and the GST-C-terminal truncation mutant were
engineered with a thrombin cleavage site. The isolated
GST-fusion proteins were treated with thrombin as
described (Smith and Johnson, 1988). Briefly, the GST-Cterminal proteins were diluted into thrombin cleavage
buffer; 50 mM Tris –HCl, 150 NaCl, 2·5 mM CaCl2, pH
7·5 and incubated overnight at either 378C or room
temperature with thrombin in a 1:1 (wt/wt) ratio. The
reaction was stopped with the addition of 2 £ SDS-sample
buffer for electrophoresis and Western blot analysis or quick
frozen in liquid nitrogen for depolarization studies, fusion
assays and column chromatography.
Purification of GST-C-terminal fusion protein products.
The full-length peripherin/rds C-terminal fusion protein was
cleaved with thrombin as described above. The cleaved Cterminal polypeptide was purified using size exclusion FPLC.
Routinely, 2 ml of sample was loaded onto a Hi-load 16/60
Superdex preparatory grade column (diameter 16 mM ; length
62 cm; Amersham Pharmacia, Uppsala, Sweden). The sample
was eluted with 0·25 M NaCl; in 0·02 M Na2 PO4, pH 7·4 at a
flow rate of 1 ml min21 and absorbance monitored at 214 nm.
The identity of the peaks was confirmed using dot blot analysis
with monoclonal antibody 2B6 and purity confirmed with
Coomasie staining of 15% SDS–PAGE based on the system
of Laemmli (Laemmli, 1970), and Western blot analysis
(Boesze-Battaglia et al., 1998). The relative sizes of the
complexes were determined by comparison to known
standards; BSA, (87 kDa), thrombin, (33·5 kDa), GST
(27·5 kDa), trypsin, (24 kDa); cytochrome c (12·4 kDa),
angiotensin (1·25 kDa), met-and leu enkephalin (0·56 kDa)
and the tripeptide, Val-Tyr-Val (0·38 kDa).
Vesicle preparation. Phospholipids were purchased from
Avanti Polar Lipids (Birmingham, AL, USA). Phosphatidylcholine (PC), phosphatidylserine (PS) and cholesterol (Chol)
were co-solubilized in cholorform in a 4:4:1molar ratio, dried
under N2 and lyopholized. Large unilamellar vesicles
(LUVs) were prepared by extrusion essentially as described
(Hope et al., 1985). Briefly, dried lipid films were lyophilized
for 4 hr and the resulting film resuspended in 5 mM Hepes,
100 mM NaCl (pH 7·4). The lipid dispersions were subjected
to 10 freeze-thaw cycles in liquid nitrogen prior to 10
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extrusion cycles. Extrusions were performed with a Nucleopore filtration device through either a membrane of 0·1 or
0·4 mm, depending on the types of assays. When the LUVs
were to be used for aqueous contents mixing assays the
fluorophores were encapsulated into the vesicles as described
below. Phosphate was determined as described by Bartlett
(1959) and modified by Litman (1973).
Resonance energy transfer (RET) assay depicting
membrane mixing. The fusion between PC/PS/CHOL
vesicles containing fluorescent probes NBD-PE and RhPE was monitored as a mixing of membrane components
using a fluorescence resonance energy transfer method as
described originally by Struck et al. (1981). Using a mixture
of fluorescently labeled and unlabeled vesicles the assay is
based on the dilution of a resonance energy transfer pair,
Rh-PE and NBD-PE. Dilution due to membrane lipid
mixing results in an increase in NBD-PE fluorescence.
Vesicles containing 0·6% (mole%) Rh-PE and 0·6%
(mole%) NBD-PE were mixed with unlabeled vesicles in
a 1:1 molar ratio. At this concentration of fluorophores, the
NBD-PE fluorescence increases linearly with the dilution of
the probe. Emission of NBD- fluorescence was monitored at
530 nm, with the excitation wavelength set at 465 nm
(rhodamine excitation). A 515 nm cutoff filter was used
between the sample and the emission monochrometer to
decrease interference from scattering.
ANTS –DPX contents mixing assays. ANTS –DPX fusion
assays were carried out to confirm protein induced aqueous
contents mixing as described by Ellens et al. (1985). LUVs
encapsulting either ANTS or DPX were prepared as
described by Szoka et al. (1980) and in further detail by
Ellens et al. (1985). Briefly, N-methyl-DOPE was hydrated
on ice, under nitrogen in 25 mM ANTS, 45 mM NaCl,
10 mM glycine, pH 9·5 or 90 mM DPX, 10 mM glycine, pH
9·5 for 3 hr. Subsequent to the freeze-thaw and extrusion
steps described above, the encapsulated fluorophores were
separated from the unencapsulated fluorophores on a
Sephadex G-50 column, with 100 mM NaCl, 10 mM
Glycine, 0·1 mM EDTA, pH 9·5 as the elution buffer. The
vesicles were used immediately for fusion assays. These
assays were carried out in a final volume of 3 ml, with a 9:1
molar ratio of DPX-containing LUVs to ANTS containing
LUVs. Fusion was initiated with a decrease in pH from 9·5
to 4·5 with the addition of 100 ml of 2 M Na acetate/acetic
acid buffer. Fluorescence intensity was monitored with
lex ¼ 380 nm and lem ¼ 510 nm: The mixing of the
aqueous contents results in the formation of an ANTS –
DPX complex with a reduced quantum yield and a
quenching of fluorescence. This decrease in fluorescence
was monitored continuously for 5– 10 min. The initial rate
of fusion (IRF) between the vesicles was calculated (Szoka
et al., 1980; Ellens et al., 1985) from the slope of
the fluorescence decay curve during the period immediately
following the initiation of fusion (first 1 – 2 min). Hundred
percent fluorescence intensity was taken to be the initial
fluorescence intensity before the decrease in pH.
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Membrane permeability studies. Membrane bilayer
destabilization was inferred from membrane depolarization
studies and measured fluorimetrically with the cation
sensitive dye, diS-C2-5, as a collapse in a valinomycin
induced diffusion potential (Kliger et al., 1997). SUVs
composed of phosphatidylcholine/phosphatidylserine/
cholesterol (PC/PS/CHOL) in a 4:4:1 molar ratio were
prepared by probe sonication in the presence of Kþ
containing buffer (50 mM K2SO4, 10 mM Hepes-SO4, pH
6·8). An aliquot of the SUVs (phospholipid
concentration ¼ 36 nmol) was added to 10 ml of isotonic
buffer (50 mM Na2SO4, 10 mM Hepes-SO4, pH 6·8) containing 10 ml of the fluorescent probe diS-C2 -5 (stock ¼ 1 mM )
and incubated at 378C until stable baseline fluorescence was
established. The addition of valinomycin (final
concentration ¼ 1027 M ), selectively permeabilized the
vesicles to Kþ, creating a negative diffusion potential inside
the vesicles resulting in the quenching of the dye’s
fluorescence. GST-C-terminal fusion proteins or purified
C-terminal polypeptide from a 1 mg ml21 stock in either
dH2O or Kþ -free buffer were added in 25, 75, or 100 ml
aliquots. Fluorescence was subsequently recorded at lex ¼
620 nm and lem ¼ 670 nm for 90 min. An increase in
fluorescence intensity upon the addition of proteins was
indicative of a dissipation of the diffusion potential due to
polypeptide induced destabilization. The percent fluorescence recovery was calculated as described (Kliger et al.,
1997), using the equation below
Ft ¼ ½ðIt 2 Io Þ=ðIf 2 Io Þ £ 100:
It is the fluorescence after the addition of the peptide, at time
t, Io is fluorescence after the addition of valinomycin,
If ¼ fluorescence intensity prior to the addition of valinomycin. Mellitin (final concentration ¼ 9·0 mg ml21) was
added to confirm that the increase in fluorescence observed
was due to a collapse in the diffusion potential. In all of the
permeability studies mellitin was able to dissipate the
valinomycin induced diffusion potential after the addition
of those proteins which had no effect.
Fluorimetric assays. Fluorescence measurements were
conducted in a Perkin – Elmer LS50B spectrofluorimeter, at
378C with continuous stirring. In all assays the kinetics of
the change in fluorescence was recorded continuously. Data
symbols are included in the figures to allow for identification of the curves.
2.1. Circular dichroism studies
Purified full-length peripherin/rds C-terminal polypeptide samples were prepared in 50 mM phosphate buffer (pH
7) for CD studies at 0·1 mg ml21. To determine the effect of
dodecylphosphatidylcholine (DPC), additional samples
were prepared as above, in which the lipid was present in
a 100:1 ratio to the polypeptide. Spectra were recorded on a
Jasco J-715 spectropolarimeter using a 1 nm bandwidth and
a 0·2 cm path length. The instrument was programmed to

average three spectra taken from 190 to 260 nm. The
predicted structure was based on algorithms using wavelengths between 205 and 260 nm. No detectable change in
intensity was observed with DPC vesicles alone. All
samples were run at least three times at room temperature.
Total protein was determined using a Bio-Rad microassay
procedure (Sigma, St Louis, MO, USA).

3. Results
3.1. Purification of the C-terminal peripherin/rds
polypeptide
Peripherin/rds has been shown to promote membrane
fusion in cell free assay systems (Boesze-Battaglia et al.,
1997; Boesze-Battaglia et al., 1998). Residues 311– 325 of
the C-terminus of peripherin/rds have been identified as the
minimal region required to promote lipid bilayer fusion
(Boesze-Battaglia et al., 1997; Boesze-Battaglia et al., 1998;
Boesze-Battaglia et al., 2000). To further investigate the
functional and structural properties of the C-terminus,
polypeptides corresponding to the entire C-terminal region
were expressed. In these studies, a bovine peripherin/rds
GST-C-terminal fusion protein, depicted schematically in
Fig. 1, was expressed in E. coli. The entire C-terminus of
peripherin/rds from residues 284 to 346 was assembled into
a construct engineered with a thrombin cleavage site. This
peptide will be referred to as the full-length peripherin/rds
C-terminal polypeptide (abbreviated PERCTER). A second
similarly engineered construct corresponding to residues
284– 318 was also generated. This truncation mutant lacks
half of the fusion domain (residues 311– 325) of peripherin
and will be referred to as the C-terminal truncation
polypeptide (abbreviated PERCTN). The GST-C-terminal
fusions were expressed in E. coli by IPTG induction at 378C
for 3 hr and purified as described in Section 2.
Expressed protein eluted with glutathione from GSTSepharose was characterized by immunobloting. An antiGST and anti-peripherin/rds mAb 2B6 immunoreactive
band with a molecular mass of 36 kDa, corresponding to the
predicted size of the GST-peripherin/rds C terminal
polypeptide was isolated in the eluant. The GST-C-terminal
polypeptide was cleaved with thrombin and the proteins in
the cleavage reaction separated by size exclusion chromatography (Fig. 2). The six isolated fractions (A – F) were run
on a 15% SDS – PAGE gel, transferred to nitrocellulose and
immunoblotted with anti-peripherin/rds mAb 2B6 and antiGST. The results of the anti-peripherin/rds blots are shown
in the inset to Fig. 2. Peak E was found to contain an 8 kDa
band that was immunoreactive with anti-peripherin/rds
mAb 2B6, no additional proteins were detected in this
fraction as shown by Coomasie staining (data not shown). In
addition a 35·5 kDa band was detected in peak B
corresponding to uncleaved protein (Fig. 2 inset). No
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Fig. 1. Schematic representation of GST-fusion Proteins. The full-length C-terminus of peripherin/rds (PERCTER) corresponding to residues 284–346 is
shown with the fusion domain indicated. The GST C-terminal truncation mutant protein (PERCTN) is also shown from residues 284 to 318, with the truncated
form of the fusion peptide domain indicated. GST refers to glutathione-S-transferase. The thrombin cleavage site is indicated by an arrow.

detectable immunoreactivity with anti peripherin/rds mAb
2B6 was observed in Peak A or F.
3.2. The full-length C-terminal polypeptide promotes
the steps of fusion
To investigate the ability of the purified C-terminus to
mediate lipid bilayer fusion, the final steps of membrane

fusion were assayed. First, the destabilization of the
membrane was inferred from membrane depolarization
studies, and second, membrane fusion was assessed both by
mixing of the bilayer lipids and mixing of the aqueous
contents (Bentz and Ellens, 1988). Biochemical and
biophysical techniques demonstrating each of these steps
have been used in previous studies to show that the synthetic
peptide (PP-5) that corresponds to the peripherin/rds fusion

Fig. 2. Purification of full-length peripherin/rds C-terminal polypeptide from GST-fusion protein. The GST-C-terminal polypeptide was cleaved with thrombin.
The resultant proteins were purified on a Hi Load Superdex column eluted with 0·025 M NaCl, 0·02 M Na2PO4 pH 7·4 at a flow rate of 1 ml min21. The eluant
was monitored at 214 nm and the peaks designated as A –F. The elution volume, which is equivalent to the elution time is indicated below the peak designation.
Inset. Immunoblot analysis of proteins in the fractions corresponding to Peaks A, B, E and F. Proteins were separated on a 15% SDS–PAGE, transferred to
nitrocellulose and immunoblotted with anti-peripherin/rds mAb 2B6.
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peptide (residues 311 – 325), can promote membrane
depolarization and membrane fusion in phospholipid
vesicles (Boesze-Battaglia et al., 1997; Boesze-Battaglia
et al., 1998; Boesze-Battaglia et al., 2000). Since we have
identified the minimal region necessary to promote fusion
we now wished to investigate how the entire C-terminal
domain participates in this process.
3.3. Membrane depolarization
Membrane destabilization can be indirectly measured as
an increase in membrane permeability that is monitored
experimentally as a dissipation of a diffusion potential in a
model membrane system. Phospholipid vesicles consisting
of PC/PS/CHOL were prepared in a Kþ containing buffer as
described in Section 2. Upon addition of valinomycin, Kþ
selectively exits the vesicles and establishes a membrane
potential across the bilayer. The Kþ gradient can be detected
as a change in the fluorescence of the cation sensitive dye,
diS-C2-5. Membrane destabilization, inferred from the
collapse of this gradient can be detected as an increase in
fluorescence.
The ability of the C-terminal polypeptide and the
truncated polypeptide to destabilize the bilayer was tested
by addition of each of these to a suspension of vesicles in
which a Kþ gradient was established in the presence of diSC2-5. A polypeptide that promotes membrane depolarization likely does so by destabilizing the bilayer thus
increasing its permeability. Fig. 3(A) shows representative
depolarization experiments. The purified, peripherin/rds Cterminal (PERCTER) polypeptide was able to promote
membrane depolarization as indicated by the increase in
fluorescence. During the same time period the truncated Cterminal polypeptide (PERCTN) did not promote membrane
depolarization. Therefore, membrane depolarization
(indicative of destabilization) required the fusion peptide
domain, residues 311 – 325. The ability to depolarize the
model membranes was found to be correlated to the amount
of purified polypeptide added as shown in Fig. 3(B). The
highest percent depolarization was observed at a 50:50 mix
of phospholipid to polypeptide (mole/mole). The basal
levels of depolarization, change in fluorescence in the
absence of added peptide corresponds to less than 2%
depolarization (data not shown).
Complete membrane fusion requires that localized
membrane destabilization is followed by mixing of both
the bilayer lipids and the aqueous contents of the vesicles.
The ability of the GST-C-terminus and the purified Cterminal polypeptide to promote fusion was determined
using two different assays; one assay measured lipid mixing
the other aqueous contents mixing.
3.4. Lipid bilayer mixing
Mixing of the bilayer lipids of large unilamellar
PC/PS/CHOL vesicles was monitored using a fluorescence

resonance energy transfer. Vesicles were prepared that
contained the lipid soluble fluorescent probes, Rh-PE and
NBD-PE at sufficiently high concentration in the bilayer to
quench their fluorescence. These labelled vesicles were then
mixed with unlabeled vesicles. Mixing of the lipids from the
labelled and unlabeled vesicles was detected as an increase
in NBD-PE fluorescence. In Fig. 4(A) the initial rate of
fusion in response to the addition of purified C-terminal
polypeptide is shown. The purified C-terminal peptide was
found to promote fusion as detected by bilayer lipid mixing.
In contrast, addition of the truncated C-terminal (PERCTN)
polypeptide resulted in no change in fluorescence intensity
(data not shown, suggesting that it is unable to promote lipid
mixing.
3.5. Aqueous contents mixing
It is not sufficient to demonstrate fusion by lipid mixing
only. A number of fusion proteins, such as the hemagglutinin, have been shown to induce hemifusion, that is lipid
mixing in the absence of complete aqueous contents mixing
(Kliger et al., 1997). To assess whether the purified Cterminal polypeptide could promote aqueous contents
mixing, two sets of large unilamellar vesicles, one containing the soluble fluorophore, ANTS and the other containing
the soluble fluorophore, DPX were mixed. If the aqueous
contents of the two vesicles mix an ANTS –DPX complex is
formed and the fluorescence is quenched. As shown in Fig.
4(B), the purified C-terminal polypeptide PERCTER was
found to promote aqueous contents mixing by this criterion.
Similar results were obtained when the C-terminus of native
purified peripherin/rds was cleaved by trypsin proteolysis
and isolated in a supernatant fraction. This C-terminal
polypeptide has previously been shown to promote aqueous
contents mixing (Boesze-Battaglia et al., 1997; BoeszeBattaglia et al., 1998). The fusion peptide analogue, PP-5,
was shown to inhibit both lipid mixing and aqueous contents
mixing at concentrations similar to its inhibitory effect on
native peripherin/rds in cell free assay systems (Boesze
Battaglia et al., 1997; Boesze-Battaglia et al., 1998).
Collectively, these results demonstrate that the purified
C-terminal polypeptide is properly folded as defined by the
ability to promote depolarization and both lipid mixing and
aqueous contents mixing, i.e. complete fusion.
3.6. Analysis of secondary structure by circular dichroism
Peptides corresponding to regions of intact proteins have
been shown to exhibit the secondary structural elements
present in the intact protein. Furthermore, the fusion peptide
domain has been shown to exhibit a-helical structure
(Boesze-Battaglia et al., 1998). Far ultraviolet circular
dichroism (CD) was used to investigate the secondary
structure present in the peripherin/rds C-terminal polypeptide. As shown in Fig. 5 the C-terminal region exhibits
considerable secondary structure. The elements of
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Fig. 3. C-terminal polypeptide induced dissipation of valinomycin induced diffusion potential in phosphatidylcholine/phosphatidylethanolamine/cholesterol
SUVs. (A) The fluorescence intensity of diS-C2-5, at lex ¼ 620 nm and lem ¼ 670 nm was followed over time (minutes). The addition of either the full-length
purified C-terminal polypeptide PERCTER or the truncation mutant PERCTN is shown by an arrow. The results shown are of a representative experiment. The
phospholipid to polypeptide ratio in this sample was 50:1 (mole/mole). (B) The extent of depolarization as a function of phospholipid to pure C-terminal
polypeptide ratio as indicated. The results are an average ^ SD of four independent experiments.

the secondary structure were predicted based on the CD
spectrum using algorithms as described (Bohm et al., 1992).
The results of these studies are shown in Table 1. An ahelical region in the polypeptide is consistent with the
structure observed for the fusion peptide, PP-5, in solution
detected using FTIR (Arikawa et al., 1992).
To investigate the effect of a membrane surface on the
secondary structure of the polypeptide the CD spectrum of
the C-terminal polypeptide was determined in the presence
of the lipid surface provided by DPC vesicles. As shown in

Fig. 5, in the presence of a lipid surface the minima detected
at 222 and 208 nm are more pronounced than in the absence
of the lipid. The CD spectrum was analyzed for secondary
structure using algorithms again as described (Bohm et al.,
1992) and the results are shown in Table 1. Based on this
analysis the a-helical content of the C-terminus is markedly
increased in the presence of the lipid DPC while the antiparallel b-sheet decreases. Other structural elements remain
unchanged. This increased a-helical content of the C-terminal polypeptide has been observed in other fusion peptides
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Fig. 4. The purified C-terminal polypeptide (PERCTER) promotes on
NBD-PE, Rh-PE lipid mixing and ANTS–DPX aqueous contents mixing.
The assessment of fusogenic function of full-length C-terminal polypeptide
is shown. (A) Lipid mixing detected using resonance energy transfer
between NBD-PE and Rh-PE and is quantitated as the initial rate of fusion
(IRF),% change in fluorescence intensity per second. Fusion was initiated
with the addition of either the pure C-terminal polypeptide (C-ter) to which
PP-5 was added (C-ter þ PP-5) or GST-C-terminal polypeptide (GST Cter). (B) Aqueous contents mixing detected as a decrease in fluorescence as
a complex between vesicles containing two fluorescent probes ANTS and
DPX is formed. The vesicles were incubated with, pure C-terminal
polypeptide (c-ter), C-terminus þ PP-5 (c-ter þ PP-5) or the truncation
mutant polypeptide (c-tertrn) or truncation mutant polypeptide (c-tertrn þ
PP-5) as indicated at 378C. The phospholipid to peptide ratio is 50–60:1.

and further analysis of the tertiary structure is necessary to
predict the orientation and structural motif of the Cterminus.

4. Discussion
Rod and cone cells contain a unique tetraspanin
membrane fusion protein, peripherin/rds, the C-terminal
domain of which is essential in mediating lipid bilayer

fusion. Previous studies demonstrated that a peptide
corresponding to a conserved sequence in the C-terminal
could promote bilayer fusion. However, by analogy to other
membrane fusion proteins it is likely that additional regions
within the C-terminus are required for regulation of fusion
and recognition of the appropriate membrane surfaces
(White, 1992; Hernandez et al., 1996; Pecheur et al., 1999;
Wasserman, 1999). To investigate the structure and function
of this larger protein domain we have generated a
C-terminal peripherin/rds polypeptide (PERCTER) that
includes the fusion domain. This polypeptide can promote
each of the requisite steps in membrane fusion. In contrast, a
polypeptide that includes only a portion of the fusion
domain (PERCTN) cannot mediate fusion events. The work
herein demonstrates that the C-terminal polypeptide interacts with a lipid surface, changes conformation in the
presence of a membranous medium and induces contents
and lipid mixing of model membranes.
Moreover, this work provides compelling evidence that
the C-terminus of peripherin/rds is able to promote
membrane fusion; both lipid mixing and aqueous contents
mixing, without anchorage to the bilayer. These results
suggest that peripherin/rds dependent fusion may proceed
through a mechanism different from that of HIV, and HA
induced fusion, processes that require anchorage of the
fusion protein to the host membrane (Kliger et al., 1997).
Recently, a highly conserved region upstream of the fusion
peptide domain (Smith and Johnson, 1988) that includes a
proline at position 295 was shown to enhance fusion the
mechanism of this enhancement is presently unknown
(Stefano et al., 2002). Similar regions have been identified
as essential for conformational changes of fusion proteins in
intracellular fusion, neurotransmitter release and viral
infectivity (Laemmli, 1970; Hope et al., 1985). Collectively
the data presented herein in combination with previous
studies further supports the hypothesis that regions in
addition to the 15 amino acid long fusion peptide region
participate in peripherin/rds dependent fusion.
Membrane fusion is a thermodynamically unfavourable
event that requires a change in normal membrane bilayer
structure. Fusion proteins act by perturbing local membrane
bilayer structure. The mechanism by which a fusion protein
carries out this function has been the subject of intense
interest and is currently unresolved.
Numerous biochemical and biophysical studies have led
investigators to propose that membrane fusion proteins exist
in two major conformations; a fusogenic or stable
conformation and a pre-fusion or metastable conformation
(Carr et al., 1997). Structural changes within fusion proteins
are required to allow a fusion protein to go from the prefusion to the fusion competent state and to mediate the
formation of a fusion pore (Mellman, 1995; Pecheur et al.,
1999; Bentz, 2000). Peptide-modeling studies suggest that
sperm fertilin a (Muga et al., 1994), measles virus F1
(Epand et al., 1992) and the S protein from hepatitis B virus
(Rodriguez-Crespo et al., 1995; Rodriguez-Crespo et al.,
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Fig. 5. The effect of DPC on the CD spectrum of full-length peripherin/rdsC-terminal polypeptide (PERCTER). The CD spectrum of PERCTER (0·1 mg ml21)
was determined in 50 mM phosphate buffer, pH 7·0 (· · ·). The CD spectrum of PERCTER at the same concentration was then determined in the presence of
DPC (—). The mole ratio of DPC to PERCTER was 100:1. The spectrum of DPC at the same concentration used in the later determination is also shown (- - -).
The spectra are presented as molar ellopticity versus wavelength. The secondary structure was calculated as described in Section 2 usingwavelengths between
205 and 260 nm and is summarized in tabular form in Table 1.

1996) adopt a b-sheet structure in a lipid environment
(Pecheur et al., 1999). Alternatively at higher lipid-toprotein ratios fertilin has been shown to prefer an a-helical
conformation with a helix that inserts obliquely into the
membrane bilayer, a topology that requires the presence of
negatively charged lipids (Martin et al., 1998). An a-helical
conformation and an oblique membrane orientation is also
observed for fusion peptides of SIV (Blacklow et al., 1995),
and HIV (Carr and Kim, 1993). The increase in a-helical
content has lead to suggestions that a coiled-coil intermediate (Bentz, 2000) is the favoured conformation for a fusion
pore. Such a structural requirement is clearly supported by
the crystal structure of the membrane fusion protein HA
(Carr and Kim, 1993; Bullough et al., 1994), the HIV
ectodomain (Chan et al., 1996; Tan et al., 1997; Weissenhorn et al., 1998) and the synaptobrevin –syntaxin complex
(Sutton et al., 1998). Most striking is the observation that
both highly hydrophobic viral fusion peptide domains and
charged fusion peptides within fertilin both appear to adopt
a coiled-coiled intermediate.
The above studies indicate that fusion proteins undergo
changes in secondary structure during the process of
membrane fusion. Numerous other studies have shown
that polypeptides that correspond to protein domains exhibit
secondary structure that corresponds to that of the intact
protein. Therefore, having established that the C-terminus is
able to promote fusion we investigated the secondary
structure of this polypeptide. In aqueous solution the Cterminus exhibits a far UV circular dichroism (CD)
spectrum characteristic of a peptide with substantial
secondary structure, as shown in Fig. 5 and in Table 1.
A fusion mediating protein must interact with lipid
bilayers. Therefore it is reasonable to propose a conformational change to the fusion competent state in the presence

of a lipid surface. The CD spectrum of purified wt
peripherin/rds C-terminal polypeptide PERCTER (Fig. 5)
exhibits such an increased intensity. Analysis of the CD
spectrum indicates a striking increase in a-helical secondary
structure content when a lipid surface is provided. It is
particularly interesting to note that the structural elements
corresponding to b-turn, parallel b-sheet and random
structure remain unchanged upon interaction with the lipid
surface. The anti-parallel b-sheet is approximately halved
while the a-helix is approximately doubled. This leads to the
speculation of a localized, dramatic conformational change.
We propose that this change in secondary structure of the Cterminal PERCTER polypeptide is associated with the
transition from a pre-fusion to a fusion competent state.
Earlier results based upon synthetic peptides to the fusion
domain suggested that fusion competency requires a
tetrameric arrangement of amphiphilic a-helical peptides
(Boesze-Battaglia et al., 2002). It is tempting to propose that
the C-terminus of peripherin/rds may likewise form a fusion
Table 1
Secondary structural predictions based on CD spectra. The secondary
structure of the C-terminal polypeptide was predicted as described in
Section 2 and is indicated as the percent of the total in the absence (2DPC)
and presence (þ DPC) of a lipid surface
Predicted secondary structural characteristics

2DPC (%)

þ DPC (%)

Anti-parallel b-sheet
Parallel b-sheet
a-Helix
b-Turn
Random structure

26
4
9
26
37

14
4
19
26
36

The values listed are the average of two independent experimental
determinations.
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competent coiled-coil tetramer by disruption of an antiparallel b-sheet region.
Since a number of mutations leading to various forms of
retinal degenerative disease are located within the Cterminal domain of peripherin/rds a thorough analysis of the
structural and functional properties of the C-terminus will
provide valuable insight into the etiology of these diseases
and allow genotype-phenotype correlations. An understanding of the factors that determine the specificity and
stability of structural changes within peripherin/rds is
essential to understand of the mechanisms of photoreceptor
renewal processes, specifically disk morphogenesis and disk
shedding. While it is clear that membrane fusion is
important in each of these processes, the mechanism of
the fusion has not been elucidated. Finally, the analysis of
structural changes within the C-terminus has more far
reaching implications, given that it has been recently
proposed that the localization signal for the targeting of
this protein to the ROS also resides within this domain (Tam
et al., 2001, 2002).
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